Immunocore Holdings (IMCR) Operating Income Growth (1y) (2022 - 2026)
Immunocore Holdings (IMCR) Operating Income Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,386.07% |
| 10 | Immunocore Holdings | 1.73 Bn | 886.35 Mn | 106.24 Mn | 301.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301.33% |
| Dec 31, 2025 | -1.23% |
| Sep 30, 2025 | 15.66% |
| Jun 30, 2025 | 7.13% |
| Mar 31, 2025 | 86.35% |
| Dec 31, 2024 | -14.07% |
| Sep 30, 2024 | 39.89% |
| Jun 30, 2024 | -16.43% |
| Mar 31, 2024 | -80.25% |
| Dec 31, 2023 | 34.88% |
| Sep 30, 2023 | -294.45% |
| Jun 30, 2023 | 33.63% |
| Dec 31, 2022 | 48.65% |
| Sep 30, 2022 | 117.05% |